Free Trial
→ The Crypto Secret Wall Street Doesn’t Want You to Know (From Crypto 101 Media) (Ad) Free SLS Stock Alerts

SELLAS Life Sciences Group (SLS) SEC Filings & 10K Form

SELLAS Life Sciences Group logo
$1.18 +0.02 (+1.72%)
(As of 12/3/2024 ET)
Compare

Recent SELLAS Life Sciences Group SEC Filings

Export to Excel
DateFilerForm TypeView
11/13/2024
3:17 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
7:33 AM		HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
SELLAS Life Sciences Group (Subject)
Form SC 13G/A
10/04/2024
3:06 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:12 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:42 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:26 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
11:16 PM		SELLAS Life Sciences Group (Filer)
Form EFFECT
05/01/2024
11:16 PM		SELLAS Life Sciences Group (Filer)
Form EFFECT
04/29/2024
3:16 PM		SELLAS Life Sciences Group (Filer)
Form S-3/A
03/28/2024
3:46 PM		SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:51 PM		SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:08 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:45 AM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:37 PM		SELLAS Life Sciences Group (Filer)
Form 424B5
02/07/2024
2:01 PM		HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
SELLAS Life Sciences Group (Subject)
Form SC 13G
01/25/2024
5:00 AM		Burns John Thomas (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:00 AM		SELLAS Life Sciences Group (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:01 AM		SELLAS Life Sciences Group (Issuer)
Varian John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:02 AM		Francomano Robert (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:02 AM		SELLAS Life Sciences Group (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		Kalin Katherine Bach (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		SELLAS Life Sciences Group (Issuer)
WOOD BARBARA A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		SCHEINBERG DAVID A (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:04 AM		SELLAS Life Sciences Group (Issuer)
Stergiou Angelos M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:07 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:27 PM		SELLAS Life Sciences Group (Filer)
Form 424B5
01/03/2024
4:25 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
8:05 AM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
3:21 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLS) was last updated on 12/4/2024 by MarketBeat.com Staff
From Our Partners
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Lock in this share price before 12/5
When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...
Pacaso | Sponsored
The Crypto Secret Wall Street Doesn’t Want You to Know
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Has World War III already started?
As global tensions are rising, so does the potential of direct conflict between the US and China. That's wh...
Behind the Markets | Sponsored
Meet the NYSE traded company behind a potentially blockbuster antiviral drug
This public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...
Smallcaps Daily | Sponsored